Stay updated on Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page.

Latest updates to the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page
- Check2 days agoChange DetectedThe page’s revision/build version has been updated from **v3.5.2** to **v3.5.3**. This reflects a platform or documentation version change rather than a change to the study information.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.1%

- Check45 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.4.2 appears on the page; no changes to study details, eligibility criteria, or outcome measures are observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check81 days agoChange DetectedBanner notice about a lapse in government funding and NIH operating status was added, and the site revision was updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of Filgotinib & Lanraplenib in LMN Clinical Trial page.